LY294002 (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) is a known PI3-kinase inhibitor that induces apoptosis in various cancer cell models by down-regulating AKT/PKB activation [57,58]. This evidence concerns the gene AKT1 and cancer.